Compounding Pharmacy · Plantation, FL · 503A

Medwise Pharmacy Review

Plantation, FL (South Florida / Broward) 503A retail compounding pharmacy that markets compounded semaglutide and tirzepatide (injectable and oral) directly to patients for weight management. No public PCAB accreditation was found at the time of review.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

503A
Location: Plantation, FL
States licensed: 0
5.5
★★★☆☆2.8/5

Editorial score · methodology

Top-Rated GLP-1 Partners

Not sourced from Medwise Pharmacy — these are our highest-scored vetted telehealth partners for compounded GLP-1s, if you'd rather start with a provider we've walked through end to end.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

No insurance needed · HSA/FSA eligible · vetted by our editors

8.3

Found

Mainstream telehealth GLP-1 access

Starting price: $99/mo

Get started →Read review Found →
8.1

GobyMeds

Budget-conscious shoppers

Starting price: $159/mo

Get started →Read review GobyMeds →
7.7

Ivim Health

Budget-conscious shoppers

Starting price: $75/mo

Get started →Read review Ivim Health →
6.2

Wellorithm

Compounded GLP-1 access with oral tablet options across 49 states

Starting price: $147/mo

Get started →Read review Wellorithm →

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

We have not verified any third-party accreditations for this pharmacy beyond its state pharmacy license.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed

Medwise Pharmacy has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.

Regulatory Actions

No public FDA enforcement actions or recalls are on file in our records for Medwise Pharmacy. Regulatory status can change — verify with the FDA and your state board of pharmacy before relying on this information.

Weight Loss Rankings Score Breakdown

Accreditation & Compliance6/10
Regulatory Standing9/10
State Coverage0/10
GLP-1 Production10/10
Track Record5/10

Scores are independently researched. See our methodology for details.

Medium confidence · Last verified 2026-07-11 via editorial · How we verify provider data

Frequently Asked Questions

Medwise Pharmacy is a 503A compounding pharmacy based in Plantation, FL. It operates under state board of pharmacy licensure. We are not aware of any recent public FDA enforcement actions against the pharmacy, though compounding pharmacy regulatory history can change. Always verify current status with your state board of pharmacy.
Medwise Pharmacy is headquartered in Plantation, FL. The pharmacy is licensed to ship to 0 US states.
Medwise Pharmacy produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a 503A pharmacy, it dispenses compounded medications in response to individual patient prescriptions under state board of pharmacy oversight.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

See Top Semaglutide ProvidersAll Pharmacies
Sources & methodology — as of October 2026
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.